Detalhe da pesquisa
1.
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research.
Histopathology
; 84(6): 915-923, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433289
2.
Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.
BMC Cancer
; 22(1): 759, 2022 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35820813
3.
Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?
Hum Mutat
; 41(1): 7-16, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553104
4.
Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples.
BMC Cancer
; 20(1): 366, 2020 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32357863
5.
The new IVD Regulation 2017/746: a case study at a large university hospital laboratory in Belgium demonstrates the need for clarification on the degrees of freedom laboratories have to use lab-developed tests to improve patient care.
Clin Chem Lab Med
; 59(1): 101-106, 2020 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32692695
6.
Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories.
Br J Cancer
; 119(5): 605-614, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30140047
7.
International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.
BMC Cancer
; 18(1): 804, 2018 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30092778
8.
What's in a Name? A Coordinated Approach toward the Correct Use of a Uniform Nomenclature to Improve Patient Reports and Databases.
Hum Mutat
; 37(6): 570-5, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26920083
9.
External quality assessment unravels interlaboratory differences in quality of RAS testing for anti-EGFR therapy in colorectal cancer.
Oncologist
; 20(3): 257-62, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25657200
10.
The Significance of External Quality Assessment Schemes for Molecular Testing in Clinical Laboratories.
Cancers (Basel)
; 14(15)2022 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35954349
11.
Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys.
Virchows Arch
; 478(5): 995-1006, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33225398
12.
Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL.
Virchows Arch
; 478(3): 553-565, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33047156
13.
Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect.
Virchows Arch
; 479(2): 365-376, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686511
14.
Opportunistic genomic screening. Recommendations of the European Society of Human Genetics.
Eur J Hum Genet
; 29(3): 365-377, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33223530
15.
External Quality Assessment Schemes for Biomarker Testing in Oncology: Comparison of Performance between Formalin-Fixed, Paraffin-Embedded-Tissue and Cell-Free Tumor DNA in Plasma.
J Mol Diagn
; 22(6): 736-747, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32205291
16.
Staining Performance of ALK and ROS1 Immunohistochemistry and Influence on Interpretation in Non-Small-Cell Lung Cancer.
J Mol Diagn
; 22(12): 1438-1452, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33011443
17.
Laboratory reporting on the clinical spectrum of CFTR p.Arg117His: Still room for improvement.
J Cyst Fibros
; 19(6): 969-974, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32505523
18.
IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.
Virchows Arch
; 474(6): 681-689, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028539
19.
European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects.
Virchows Arch
; 475(1): 25-37, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719547
20.
Describing the Reportable Range Is Important for Reliable Treatment Decisions: A Multiple Laboratory Study for Molecular Tumor Profiling Using Next-Generation Sequencing.
J Mol Diagn
; 20(6): 743-753, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30055348